A Regional Growth Partnership venture capital fund announced yesterday it will invest $300,000 in a local pharmaceutical company that is to begin clinical trials in Toledo for a drug to treat Alzheimer s and other nervous-system diseases.
The Rocket Ventures investment is with Madison, Wis.-based Mithridion Inc., successor to Cognitive Pharmaceuticals Ltd., a firm set up by University of Toledo Profs. Wayne Hoss and William Messer, Jr.
Mithridion took over Cognitive Pharmaceuticals last month with $2.3 million in financing from a Wisconsin venture capital firm. Dr. Hoss said its drug for Alzheimer s differs from others by treating memory loss, confusion, and other symptoms and also getting at underlying causes of the disease and protecting the brain.
Guidelines: Please keep your comments smart and civil. Don't attack other readers personally, and keep your language decent. Comments that violate these standards, or our privacy statement or visitor's agreement, are subject to being removed and commenters are subject to being banned. To post comments, you must be a registered user on toledoblade.com. To find out more, please visit the FAQ.